AU2001283416A1 - Therapeutic compounds for ovarian cancer - Google Patents

Therapeutic compounds for ovarian cancer

Info

Publication number
AU2001283416A1
AU2001283416A1 AU2001283416A AU8341601A AU2001283416A1 AU 2001283416 A1 AU2001283416 A1 AU 2001283416A1 AU 2001283416 A AU2001283416 A AU 2001283416A AU 8341601 A AU8341601 A AU 8341601A AU 2001283416 A1 AU2001283416 A1 AU 2001283416A1
Authority
AU
Australia
Prior art keywords
seq
cell
cells
peptide
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283416A
Other languages
English (en)
Inventor
Charles A. Nicolette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2001283416A1 publication Critical patent/AU2001283416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001283416A 2000-08-17 2001-08-17 Therapeutic compounds for ovarian cancer Abandoned AU2001283416A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22624300P 2000-08-17 2000-08-17
US60226243 2000-08-17
PCT/US2001/025708 WO2002014352A2 (fr) 2000-08-17 2001-08-17 Composes therapeutiques contre le cancer des ovaires

Publications (1)

Publication Number Publication Date
AU2001283416A1 true AU2001283416A1 (en) 2002-02-25

Family

ID=22848127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283416A Abandoned AU2001283416A1 (en) 2000-08-17 2001-08-17 Therapeutic compounds for ovarian cancer

Country Status (8)

Country Link
US (1) US20020160959A1 (fr)
EP (1) EP1309625B1 (fr)
JP (1) JP2004506421A (fr)
AT (1) ATE297949T1 (fr)
AU (1) AU2001283416A1 (fr)
CA (1) CA2417152A1 (fr)
DE (1) DE60111538D1 (fr)
WO (1) WO2002014352A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901256D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
JP2004506421A (ja) 2004-03-04
ATE297949T1 (de) 2005-07-15
EP1309625B1 (fr) 2005-06-15
WO2002014352A3 (fr) 2003-01-16
CA2417152A1 (fr) 2002-02-21
US20020160959A1 (en) 2002-10-31
WO2002014352A9 (fr) 2004-03-04
EP1309625A2 (fr) 2003-05-14
DE60111538D1 (de) 2005-07-21
WO2002014352A2 (fr) 2002-02-21

Similar Documents

Publication Publication Date Title
US8029796B2 (en) Therapeutic anti-cytomegalovirus compounds
US6737062B2 (en) Immunogenic compositions
WO2001068677A2 (fr) Composes therapeutiques
US20060159662A1 (en) Therapeutic anti-melanoma compounds
US20020182218A1 (en) Therapeutic anti-melanoma compounds
US20040138135A1 (en) Therapeutic compounds for ovarian cancer
US20020169132A1 (en) Therapeutic anti-melanoma compounds
US20020160959A1 (en) Therapeutic compounds for ovarian cancer